C4 Therapeutics (CCCC) PT Raised to $51 at Jefferies Ahead of CFT7455 Initiation
Tweet Send to a Friend
Jefferies analyst Biren Amin raised the price target on C4 Therapeutics (NASDAQ: CCCC) to $51.00 (from $34.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
